在伊利乌姆主导vs. 结肠克罗恩病的真实世界乌斯特基努马布经验
Sandy Vien1, Elvis Jovanie Arteaga2,3, Sirisha Grandhe4
1Department of Internal Medicine, University of California, Davis, Sacramento, CA, USA.
Crohn's & colitis 360
|November 26, 2024
概括
乌斯特基努马布在结肠克罗恩病 (CD) 中显示出更好的内镜愈合,而不是在阴茎主导的CD中. 疾病的位置是预测克罗恩病患者ustekinumab治疗有效性的关键因素.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床治疗学 临床治疗学
背景情况:
- 克罗恩氏病 (CD) 呈现出多种不同的临床表现.
- 对CD解剖位置对治疗结果的影响仍然不够理解.
- 在不同CD表型中研究ustekinumab的疗效至关重要.
研究的目的:
- 评估和比较ustekinumab在患有大肠主导CD和结肠主导CD的患者中的实际有效性.
- 为了确定疾病的位置是否会影响使用乌斯特基努马布治疗的内镜愈合率.
主要方法:
- 对成年CD患者接受ustekinumab治疗的回顾性分析.
- 患者的分层分为以皮质主导和结肠主导的CD组.
- 主要结局:在随访结肠镜检查时没有;次要结局:CRP,calprotectin,住院和手术率.
主要成果:
- 76%的结肠CD患者实现了无的状态,相比之下,结肠CD患者中有45%的结肠CD患者 (P=.02).
- 在患有先前存在的的患者中,67%的结肠CD和24%的阴茎主导CD变得无 (P=.01).
- 住院和手术率,以及CRP和calprotectin水平,在治疗后的组之间是相似的.
结论:
- 乌斯特基努马布治疗与结肠CD相比,结肠CD具有优越的内镜治疗.
- 解剖学疾病位置可以作为克罗恩病中乌斯特基努马布反应的预测标记.
- 需要进一步的研究来阐明ustekinumab在CD表型中的差异性疗效.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.2K
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
938
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
01:30Inflammatory Bowel Disease II: Crohn's Disease
185
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
185
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
138
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
138
01:21Inflammatory Bowel Disease V: Surgical Management
121
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
121
01:29Inflammatory Bowel Disease IV: Pharmacological Management
113
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
113